New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 21, 2012
17:14 EDTALXAAlexza's Adasuve FDA approval has several post approval requirements
Alexza has several post-approval requirements, including a large observational clinical trial designed to gather patient safety data based on the real-world use of Adasuve, as well as a clinical program addressing the safety and efficacy of Adasuve in agitated adolescent patients.
News For ALXA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 22, 2015
09:11 EDTALXAAlexza Pharmaceuticals initiates Phase 2a study of AZ-002 in epilepsy
Alexza Pharmaceuticals has initiated a Phase 2a study of AZ-002 - Staccato alprazolam -, which is being developed for the management of epilepsy in patients with acute repetitive seizures. ARS occurs in a subset of patients with epilepsy who regularly experience breakthrough seizures, despite treatment with a regular regimen of anti-epileptic drugs. Alexza expects to announce results from this study in 1H15.
09:11 EDTALXAAlexza Pharmaceuticals initiates Phase 2a study of AZ-002 in epilepsy
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use